Balancing the effective sample size in prior across different doses in the curve-free Bayesian decision-theoretic design for dose-finding trials

Jiapeng Xu, Dehua Bi, Shenghua Kelly Fan +2

The primary goal of dose allocation in phase I trials is to minimize patient exposure to subtherapeutic or excessively toxic doses, while accurately recommending a phase II dose th…